168 related articles for article (PubMed ID: 34851425)
1. Dexmedetomidine Clearance Decreases with Increasing Drug Exposure: Implications for Current Dosing Regimens and Target-controlled Infusion Models Assuming Linear Pharmacokinetics.
Alvarez-Jimenez R; Weerink MAS; Hannivoort LN; Su H; Struys MMRF; Loer SA; Colin PJ
Anesthesiology; 2022 Feb; 136(2):279-292. PubMed ID: 34851425
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
[TBL] [Abstract][Full Text] [Related]
3. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers.
Dyck JB; Maze M; Haack C; Azarnoff DL; Vuorilehto L; Shafer SL
Anesthesiology; 1993 May; 78(5):821-8. PubMed ID: 8098191
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Dexmedetomidine in Infants and Children After Orthotopic Liver Transplantation.
Damian MA; Hammer GB; Elkomy MH; Frymoyer A; Drover DR; Su F
Anesth Analg; 2020 Jan; 130(1):209-216. PubMed ID: 30198929
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients.
Iirola T; Ihmsen H; Laitio R; Kentala E; Aantaa R; Kurvinen JP; Scheinin M; Schwilden H; Schüttler J; Olkkola KT
Br J Anaesth; 2012 Mar; 108(3):460-8. PubMed ID: 22277665
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of dexmedetomidine in infants after open heart surgery.
Su F; Nicolson SC; Gastonguay MR; Barrett JS; Adamson PC; Kang DS; Godinez RI; Zuppa AF
Anesth Analg; 2010 May; 110(5):1383-92. PubMed ID: 20418300
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of dexmedetomidine during analgosedation in ICU patients.
Smuszkiewicz P; Wiczling P; Ber J; Warzybok J; Małkiewicz T; Matysiak J; Klupczyńska A; Trojanowska I; Kokot Z; Grześkowiak E; Krzyzanski W; Bienert A
J Pharmacokinet Pharmacodyn; 2018 Apr; 45(2):277-284. PubMed ID: 29290034
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-inducing anticonvulsants increase plasma clearance of dexmedetomidine: a pharmacokinetic and pharmacodynamic study.
Flexman AM; Wong H; Riggs KW; Shih T; Garcia PA; Vacas S; Talke PO
Anesthesiology; 2014 May; 120(5):1118-25. PubMed ID: 24487703
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of sifalimumab, an investigational anti-interferon-α monoclonal antibody, in systemic lupus erythematosus.
Narwal R; Roskos LK; Robbie GJ
Clin Pharmacokinet; 2013 Nov; 52(11):1017-27. PubMed ID: 23754736
[TBL] [Abstract][Full Text] [Related]
11. Development of an Optimized Pharmacokinetic Model of Dexmedetomidine Using Target-controlled Infusion in Healthy Volunteers.
Hannivoort LN; Eleveld DJ; Proost JH; Reyntjens KM; Absalom AR; Vereecke HE; Struys MM
Anesthesiology; 2015 Aug; 123(2):357-67. PubMed ID: 26068206
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients.
Ber J; Wiczling P; Hołysz M; Klupczyńska A; Bartkowska-Śniatkowska A; Bieda K; Smuszkiewicz P; Nowicka M; Żurański Ł; Sobczyński P; Matysiak J; Grześkowiak E; Bienert A
J Clin Pharmacol; 2020 Nov; 60(11):1461-1473. PubMed ID: 32500578
[TBL] [Abstract][Full Text] [Related]
13. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
Fabre MA; Fuseau E; Ficheux H
J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of dexmedetomidine administered to patients with end-stage renal failure and secondary hyperparathyroidism undergoing general anaesthesia.
Zhong W; Zhang Y; Zhang MZ; Huang XH; Li Y; Li R; Liu QW
J Clin Pharm Ther; 2018 Jun; 43(3):414-421. PubMed ID: 29247451
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients.
Iirola T; Aantaa R; Laitio R; Kentala E; Lahtinen M; Wighton A; Garratt C; Ahtola-Sätilä T; Olkkola KT
Crit Care; 2011; 15(5):R257. PubMed ID: 22030215
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis.
Potts AL; Anderson BJ; Warman GR; Lerman J; Diaz SM; Vilo S
Paediatr Anaesth; 2009 Nov; 19(11):1119-29. PubMed ID: 19708909
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass.
Zimmerman KO; Wu H; Laughon M; Greenberg RG; Walczak R; Schulman SR; Smith PB; Hornik CP; Cohen-Wolkowiez M; Watt KM
Anesth Analg; 2019 Dec; 129(6):1519-1528. PubMed ID: 31743171
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of dexmedetomidine-induced vasoconstriction in healthy volunteers.
Talke P; Anderson BJ
Br J Clin Pharmacol; 2018 Jun; 84(6):1364-1372. PubMed ID: 29495085
[TBL] [Abstract][Full Text] [Related]
19. Morphine Glucuronidation and Elimination in Intensive Care Patients: A Comparison with Healthy Volunteers.
Ahlers SJ; Välitalo PA; Peeters MY; Gulik Lv; van Dongen EP; Dahan A; Tibboel D; Knibbe CA
Anesth Analg; 2015 Nov; 121(5):1261-73. PubMed ID: 26332855
[TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetics of Intranasal Dexmedetomidine in Infants and Young Children.
Li BL; Guan YP; Yuen VM; Wei W; Huang M; Zhang MZ; Li AW; Standing JF; Zhong GP; Song XR
Anesthesiology; 2022 Aug; 137(2):163-175. PubMed ID: 35503980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]